Surrozen (SRZN) Director Mary Haak‑Frendscho Receives Award of 5,550 Shares

What Happened

• Director Mary Haak‑Frendscho received a derivative award covering 5,550 shares on 2026-05-13. The filing shows $0.00 paid at grant (typical for option/award grants reported as derivative instruments). This is a grant of equity compensation to a director rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-13; Form 4 filed: 2026-05-14 (timely; Form 4 due within two business days)
• Transaction type/code: A — Grant/award (derivative)
• Shares/units granted: 5,550 (reported at $0.00 cash paid)
• Shares owned after transaction: Not disclosed in the provided excerpt
• Footnote: F1 — The options vest and become exercisable on the anniversary of the grant date, subject to continuous service as a director
• Filing timeliness: Timely (no late filing flag in provided data)

Context

• This is a standard director equity grant (compensation), not a purchase or sale in the market. As a derivative award, the grant gives rights to future shares subject to vesting and exercisability; it does not represent an immediate sale or acquisition of common stock. Such awards are common for director compensation and do not by themselves indicate the director's view on the stock.